Rock Springs Capital Management LP Axonics, Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $2.86 Million - $4.98 Million	-125,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $16 Million - $36.8 Million	-975,000 Reduced 88.64%	125,000 $3.18 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $17.6 Million - $26 Million	897,500 Added 443.21%	1,100,000 $30.5 Million
Q3 2019 Nov 14, 2019	SELL	$26.92 - $42.41 $5.32 Million - $8.38 Million	-197,500 Reduced 49.38%	202,500 $5.45 Million
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $5.28 Million - $6.57 Million	400,000 New	400,000 $6.04 Million

235

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.